This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Villares, G. J. Articles by Bar-Eli, M. Search for Related Content PubMed PubMed Citation Articles by Villares, G. J. Articles by Bar-Eli, M.

Targeting Melanoma Growth and Metastasis with Systemic Delivery of Liposome-Incorporated Protease-Activated Receptor-1 Small Interfering RNA

Departments of ¹ Cancer Biology, ² Experimental Therapeutics, and ³ Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Menashe Bar-Eli, Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Box 173, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-794-4004; Fax: 713-792-8747; E-mail: mbareli{at}mdanderson.org.

Key Words: Thrombin Receptor • Melanoma • Liposome • siRNA • shRNA

The thrombin receptor [protease-activated receptor-1 (PAR-1)] is overexpressed in highly metastatic melanoma cell lines and in patients with metastatic lesions. Activation of PAR-1 leads to cell signaling and up-regulation of genes involved in adhesion, invasion, and angiogenesis. Herein, we stably silence PAR-1 through the use of lentiviral short hairpin RNA and found significant decreases in both tumor growth (P < 0.01) and metastasis (P < 0.001) of highly metastatic melanoma cell lines in vivo. The use of viruses for therapy is not ideal as it can induce toxic immune responses and possible gene alterations following viral integration. Therefore, we also used systemic delivery of PAR-1 small interfering RNA (siRNA) incorporated into neutral liposomes [1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC)] to decrease melanoma growth and metastasis in vivo. Significant decreases in tumor growth, weight, and metastatic lung colonies (P < 0.001 for all) were found in mice treated with PAR-1 siRNA-DOPC. The in vivo effects of PAR-1 on invasion and angiogenesis were analyzed via immunohistochemistry. Concomitant decreases in vascular endothelial growth factor, interleukin-8, and matrix metalloproteinase-2 expression levels, as well as decreased blood vessel density (CD31), were found in tumor samples from PAR-1 siRNA-treated mice, suggesting that PAR-1 is a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors. We propose that siRNA incorporated into DOPC nanoparticles could be delivered systemically and used as a new modality for melanoma treatment. [Cancer Res 2008;68(21):9078–86]

This article has been cited by other articles:

				S. Jiang, M. K. Gnanasammandhan, and Y. Zhang Optical imaging-guided cancer therapy with fluorescent nanoparticles J R Soc Interface, January 6, 2010; 7(42): 3 - 18. [Abstract] [Full Text] [PDF]

				A. Lasham, M. Herbert, N. Coppieters 't Wallant, R. Patel, S. Feng, M. Eszes, H. Cao, and G. Reid A rapid and sensitive method to detect siRNA-mediated mRNA cleavage in vivo using 5' RACE and a molecular beacon probe Nucleic Acids Res., November 26, 2009; (2009) gkp1076v1. [Abstract] [Full Text] [PDF]

				V. O. Melnikova, K. Balasubramanian, G. J. Villares, A. S. Dobroff, M. Zigler, H. Wang, F. Petersson, J. E. Price, A. Schroit, V. G. Prieto, et al. Crosstalk between Protease-activated Receptor 1 and Platelet-activating Factor Receptor Regulates Melanoma Cell Adhesion Molecule (MCAM/MUC18) Expression and Melanoma Metastasis J. Biol. Chem., October 16, 2009; 284(42): 28845 - 28855. [Abstract] [Full Text] [PDF]

				A. S. Dobroff, H. Wang, V. O. Melnikova, G. J. Villares, M. Zigler, L. Huang, and M. Bar-Eli Silencing cAMP-response Element-binding Protein (CREB) Identifies CYR61 as a Tumor Suppressor Gene in Melanoma J. Biol. Chem., September 18, 2009; 284(38): 26194 - 26206. [Abstract] [Full Text] [PDF]

				G. J. Villares, A. S. Dobroff, H. Wang, M. Zigler, V. O. Melnikova, L. Huang, and M. Bar-Eli Overexpression of Protease-Activated Receptor-1 Contributes to Melanoma Metastasis via Regulation of Connexin 43 Cancer Res., August 15, 2009; 69(16): 6730 - 6737. [Abstract] [Full Text] [PDF]

				E. KUWADA, K. NOGUCHI, N. SEO, H. YAMASHIRO, and K. EGAWA A Novel Strategy of Cancer Gene Therapy by Transcriptional Targeting of an Allogeneic Histocompatibility Transgene Anticancer Res, April 1, 2009; 29(4): 1015 - 1022. [Abstract] [Full Text] [PDF]